Browse Data and Analysis
Filter
Search Data and Analysis
- 5 results found
- (-) November 2024
- (-) Burma
- (-) Israel
- Clear all
Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology since 2023.
The beef sector in Israel is growing and is heavily reliant upon imports. Israel’s lack of grazing land for cattle and an increasing population are the main factors contributing to the growth in demand for beef imports.
With over 2,500 facilities, the Israeli food processing sector is an important player in the domestic economy. In 2022, Israeli food processors' annual revenue stood at $23.19 billion.
This report described Burma’s current production, regulations and trade for genetically engineered products, as well as recent activities focused on agricultural biotechnology. Burma’s (also called Myanmar) National Biosafety Framework and Biosafety Guidelines have been pending approval by the Ministry of Agriculture since before the 2021 coup.
This report supplements GAIN report IS2-24-0020: Israel Adopts Additional European Union Standards for Agricultural Imports and includes translations of the documents from Hebrew to English referenced in the report.